tiprankstipranks
Advertisement
Advertisement

LBRX Stock Latest News

LB Pharmaceuticals price target raised to $37 from $31 at Roth Capital
The FlyLB Pharmaceuticals price target raised to $37 from $31 at Roth Capital
3d ago
LBRX
LB Pharmaceuticals reports Q1 EPS (67c), consensus (67c)
PremiumThe Fly
LB Pharmaceuticals reports Q1 EPS (67c), consensus (67c)
8d ago
LBRX
LB Pharmaceuticals initiated with a Buy at H.C. Wainwright
PremiumThe Fly
LB Pharmaceuticals initiated with a Buy at H.C. Wainwright
24d ago
LBRX
LB-102 Bipolar Depression Trial Moves Forward: What LBRX Investors Should Know
PremiumCompany Announcements
LB-102 Bipolar Depression Trial Moves Forward: What LBRX Investors Should Know
1M ago
LBRX
Craig-Hallum bullish on LB Pharmaceuticals, initiates with a Buy
PremiumThe Fly
Craig-Hallum bullish on LB Pharmaceuticals, initiates with a Buy
1M ago
LBRX
LB Pharmaceuticals initiated with a Buy at Craig-Hallum
PremiumThe FlyLB Pharmaceuticals initiated with a Buy at Craig-Hallum
1M ago
LBRX
LB Pharmaceuticals files to sell 4.78M shares of common stock for holders
Premium
The Fly
LB Pharmaceuticals files to sell 4.78M shares of common stock for holders
1M ago
LBRX
LB Pharmaceuticals price target raised to $40 from $35 at Stifel
Premium
The Fly
LB Pharmaceuticals price target raised to $40 from $35 at Stifel
2M ago
LBRX
LB Pharmaceuticals reports Q4 EPS (45c), consensus (32c)
PremiumThe Fly
LB Pharmaceuticals reports Q4 EPS (45c), consensus (32c)
2M ago
LBRX
LB Pharmaceuticals initiates NOVA-2 trial
PremiumThe Fly
LB Pharmaceuticals initiates NOVA-2 trial
2M ago
LBRX
LB Pharmaceuticals Announces Director Zachary Prensky’s Planned Retirement
PremiumCompany Announcements
LB Pharmaceuticals Announces Director Zachary Prensky’s Planned Retirement
2M ago
8K
LBRX
LB Pharmaceuticals adds neuroscience leader to board, governance
PremiumCompany Announcements
LB Pharmaceuticals adds neuroscience leader to board, governance
2M ago
8K
LBRX
LB Pharmaceuticals appoints Lenz to Board of Directors
PremiumThe FlyLB Pharmaceuticals appoints Lenz to Board of Directors
2M ago
LBRX
LB Pharmaceuticals management to meet with Piper Sandler
Premium
The Fly
LB Pharmaceuticals management to meet with Piper Sandler
3M ago
LBRX
LB Pharmaceuticals Announces $100 Million Private Placement Financing
Premium
Company Announcements
LB Pharmaceuticals Announces $100 Million Private Placement Financing
3M ago
8K
LBRX
LB Pharmaceuticals prices 3.31M shares at $21.17 in private placement
PremiumThe Fly
LB Pharmaceuticals prices 3.31M shares at $21.17 in private placement
3M ago
LBRX
LB Pharmaceuticals Advances LB-102 Into Long-Term Phase 3 Safety Study for Schizophrenia
PremiumCompany Announcements
LB Pharmaceuticals Advances LB-102 Into Long-Term Phase 3 Safety Study for Schizophrenia
4M ago
LBRX
LB Pharmaceuticals initiates Phase 2 trial of LB-102
PremiumThe Fly
LB Pharmaceuticals initiates Phase 2 trial of LB-102
4M ago
LBRX
LB Pharmaceuticals Advances LB-102 Into Phase 3, Setting Up a Key Schizophrenia Catalyst for Investors
PremiumCompany Announcements
LB Pharmaceuticals Advances LB-102 Into Phase 3, Setting Up a Key Schizophrenia Catalyst for Investors
4M ago
LBRX
LB Pharmaceuticals appoints Pazdera as General Counsel
PremiumThe FlyLB Pharmaceuticals appoints Pazdera as General Counsel
4M ago
LBRX
LB Pharmaceuticals initiated with a Buy at Roth Capital
Premium
The Fly
LB Pharmaceuticals initiated with a Buy at Roth Capital
4M ago
LBRX
LB Pharmaceuticals appoints Ellen Rose as SVP, corporate affairs
Premium
The Fly
LB Pharmaceuticals appoints Ellen Rose as SVP, corporate affairs
4M ago
LBRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >